1. Reproductive health in individuals with homozygous β-thalassemia: knowledge, attitudes, and behavior 
Vicki Psihogios, M.D., Christine Rodda, Ph.D., Elizabeth Reid, R.N., Malcolm Clark, Ph.D., Caroline Clarke, M.D., Donald Bowden, M.D. 
Fertility and Sterility 
Volume 77, Issue 1, Pages (January 2002)
DOI: /S (01)

2. FIGURE 1
(A), Gonadal status (n = 56). The black shaded area represents hypogonadal participants; the white area represents participants with normal gonadal status. (B), Proportion of hypogonadal women (n = 35) who were receiving hormone replacement therapy (HRT). The black shaded area represents those taking HRT; the gray shaded area represents those who declined HRT; and the white area represents those in whom HRT or oral contraception was contraindicated.
Psihogios. Reproductive health in homozygous -thalassemia. Fertil Steril 2002.
Fertility and Sterility  , DOI: ( /S (01) )

3. FIGURE 2
(A), Gonadal status. The black shaded area represents hypogonadal participants; the white area represents participants with normal gonadal status. (B), Proportion of hypogonadal men (n = 20) who were receiving various preparations of testosterone replacement. The black shaded area represents those receiving injections of testosterone propionate, 20 mg, phenylpropionate, 40 mg, and isocaproate, 40 mg; the gray shaded area represents those taking testosterone undecenoate tablets; the striped area represents those who received testosterone implants; and the white area represents those who received no hormone replacement therapy.
Psihogios. Reproductive health in homozygous -thalassemia. Fertil Steril 2002.
Fertility and Sterility  , DOI: ( /S (01) )